32 results on '"PIGNOT, Marc"'
Search Results
2. Real-World Burden of Immunosuppressant-Treated Lupus Nephritis: A German Claims Database Analysis
3. The Impact of Systemic Lupus Erythematosus Flares on Clinical and Economic Outcomes: The CHAMOMILE Claims Database Study in Germany
4. Impact of COPD on mortality: An 8-year observational retrospective healthcare claims database cohort study
5. Real-world effectiveness of osteoporosis treatments in Germany
6. Correction: Real-world effectiveness of osteoporosis treatments in Germany
7. Klinische Verläufe und Kosten für Hospitalisierungen von COVID-19-Patienten mit potenziell eingeschränktem Immunsystem in Deutschland
8. The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization
9. Unveiling the untreated: development of a database algorithm to identify potential Fabry disease patients in Germany.
10. Clinical and economic burden of organ damage among patients with systemic lupus erythematosus in a real-world setting in Germany.
11. Comorbidities, healthcare resource utilization & treatment pattern among patients with prurigo nodularis, compared to a benchmark in Germany: A real- world evidence claims data study.
12. Comorbidities, healthcare resource utilization & treatment pattern among patients with prurigo nodularis, compared to a benchmark in Germany: A real‐world evidence claims data study
13. Impact of COPD on mortality: An 8-year observational retrospective healthcare claims database cohort study
14. Real-World Burden of Immunosuppressant-Treated Lupus Nephritis: A German Claims Database Analysis
15. Improvement of Hepatic and Extrahepatic Complications from Chronic Hepatitis C After Antiviral Treatment: A Retrospective Analysis of German Sickness Fund Data
16. Clinical and Economic Burden of Hepatic and Extrahepatic Complications from Chronic Hepatitis C: A Retrospective Analysis of German Sickness Fund Data
17. Corticosteroid use in patients with systemic lupus erythematosus in Germany: The CHAMOMILE claims database study
18. MO505: Prevalence of Lupus Nephritis Among Patients With Systemic Lupus Erythematosus In Germany
19. Economic Burden of Organ Damage in Systemic Lupus Erythematosus: Results From a German Claims Analysis
20. COPD Exacerbation History and Impact on Future Exacerbations – 8-Year Retrospective Observational Database Cohort Study from Germany
21. COPD Exacerbation History and Impact on Future Exacerbations – 8-Year Retrospective Observational Database Cohort Study from Germany
22. Burden of illness of Fabry disease: A retrospective claims analysis of a German sickness fund database
23. Risk of future exacerbations among COPD patients – a real-world register-based cohort study (AvoidEx)
24. Using Data from a Sickness Fund Claims Database to Assess the Treatment Patterns and Healthcare Resource Utilization among Patients with Metastatic Renal Cell Carcinoma in Germany
25. Recurrent hyperkalaemia management and use of renin–angiotensin–aldosterone system inhibitors: a European multi-national targeted chart review
26. How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study
27. Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database Analysis.
28. Recurrent hyperkalaemia management and use of renin–angiotensin–aldosterone system inhibitors: a European multi-national targeted chart review.
29. FP364THE DILEMMA OF RECURRENT HYPERKALAEMIA MANAGEMENT AND USE OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS: A EUROPEAN MULTI-NATIONAL TARGETED CHART REVIEW
30. Correction: Real-world effectiveness of osteoporosis treatments in Germany.
31. [Clinical courses and costs for hospitalizations of potentially immunocompromised COVID-19 patients in Germany].
32. Real-world effectiveness of osteoporosis treatments in Germany.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.